Literature DB >> 315930

Serum and sputum antibiotic levels after ampicillin, amoxycillin and bacampicillin chronic bronchitis patients.

B Davies, F Maesen.   

Abstract

Serum and sputum concentrations of ampicillin or amoxycillin were measured in patients admitted to hospital for acute exacerbations of chronic bronchitis with purulent sputum. Mean peak serum levels of nearly 12 mg/l were found after 1600 mg bacampicillin (mean peak level in sputum 0.85 mg/l). The serum and sputum concentrations after 750 mg amoxycillin and 800 mg bacampicillin were comparable (mean peak serum levels approximately 9.5 mg/l, sputum concentrations 0.4 to 0.5 mg/l) although the drugs were not given in equimolar doses. Results after 1000 mg ampicillin by mouth were less satisfactory (mean peak serum level 7.8 mg/l) and only 0.25 mg/l was attained in the sputum. Minimum inhibitory concentrations of ampicillin and amoxycillin were measured for 177 Haemophilus influenzae strains. Most of the ampicillin MIC values were between 0.125 and 0.5 mg/l but more of the strains required 0.5 mg/l of amoxycillin. The amoxycillin MIC values were often one or two dilutions higher than those of ampicillin (p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315930     DOI: 10.1007/bf01659773

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN: SOME PHARMACOLOGICAL OBSERVATION.

Authors:  J R MAY; D M DELVES
Journal:  Lancet       Date:  1965-05-01       Impact factor: 79.321

2.  Antibiotic resistance in Streptococcus pneumoniae and Haemophilus influenzae. Report of a study group on bacterial resistance.

Authors:  A J Howard; C J Hince; J D Williams
Journal:  Br Med J       Date:  1978-06-24

3.  Resistance of Haemophilus influenzae to trimethoprim.

Authors:  J R May; J Davies
Journal:  Br Med J       Date:  1972-08-12

4.  Bacampicillin in acute exacerbations of chronic bronchitis--a dose-range study.

Authors:  F P Maesen; H Beeuwkes; B I Davies; H J Buytendijk; P J Brombacher; J Wessman
Journal:  J Antimicrob Chemother       Date:  1976-09       Impact factor: 5.790

5.  Twice daily dosage of bacampicillin in chronic bronchitis. A double-blind study.

Authors:  B I Davies; F P Maesen; P J Brombacher; J Sjövall
Journal:  Scand J Respir Dis       Date:  1978-10

6.  Tetracycline resistance in pneumococci and group A streptococci. Report of an ad-hoc study group on antibiotic resistance.

Authors: 
Journal:  Br Med J       Date:  1977-01-15

7.  Sputum and serum levels of amoxycillin in chronic bronchial infections.

Authors:  A Ingold
Journal:  Br J Dis Chest       Date:  1975-07

8.  Haemophilus influenzae type B resistant to tetracycline isolated from children with meningitis.

Authors:  D Hansman
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

9.  Sensitivity of Haemophilus influenzae to antibiotics.

Authors:  J D Williams; J Andrews
Journal:  Br Med J       Date:  1974-01-26
  9 in total
  11 in total

1.  The quinolones in chronic bronchitis.

Authors:  B I Davies; F P Maesen; J P Teengs; C Baur
Journal:  Pharm Weekbl Sci       Date:  1986-02-21

2.  Ampicillin and alternatives.

Authors:  A Dyas; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

3.  Bacampicillin treatment of pneumococcal pneumonia in high risk patients.

Authors:  S Campbell
Journal:  Bull N Y Acad Med       Date:  1983-06

4.  Bacampicillin in the treatment of acute sinusitis and bronchopulmonary disease.

Authors:  J P Simelaro; C Henwood; A Desalvo
Journal:  Bull N Y Acad Med       Date:  1983-06

5.  Comparative activities of antibiotics against intracellular non-typeable Haemophilus influenzae.

Authors:  Christina Kratzer; Wolfgang Graninger; Karin Macfelda; Astrid Buxbaum; Apostolos Georgopoulos
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

Review 6.  Studies on aminopenicillin developments. Proceedings of a symposium. Concluding remarks.

Authors:  T Bergan
Journal:  Infection       Date:  1979       Impact factor: 3.553

Review 7.  The aminopenicillins: development and comparative properties.

Authors:  D S Reeves; D W Bullock
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  [New oral quinolone compounds in chronic bronchitis].

Authors:  B I Davies; F P Maesen; J P Teengs; C Baur
Journal:  Infection       Date:  1986       Impact factor: 3.553

9.  Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.

Authors:  B I Davies; F P Maesen; C Baur
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

10.  Amoxicillin concentrations in relation to beta-lactamase activity in sputum during exacerbations of chronic obstructive pulmonary disease.

Authors:  Marjolein Brusse-Keizer; Paul VanderValk; Rogier W van der Zanden; Lars Nijdam; Job van der Palen; Ron Hendrix; Kris Movig
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.